Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
Go back to Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease| (NASDAQ: ACOG) | Delayed: 6.76 -0.15 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.91 | 52 Week High | $ | |||
| Open | $7.00 | 52 Week Low | $ | |||
| Day High | $7.03 | P/E | N/A | |||
| Day Low | $6.73 | EPS | $ | |||
| Volume | 14,242 | |||||
